Straits Times Index
3,323.20 -6.89 (-0.21%) S&P 500
5,306.04 +1.32 (+0.02%) Dow
38,852.86 -216.74 (-0.55%) Nasdaq
17,019.88 +99.08 (+0.59%) Bitcoin USD
67,774.30 -456.90 (-0.67%) CMC Crypto 200
1,461.75 -22.94 (-1.55%)
ATXS Oct 2024 12.500 call
| Previous close | 0.7000 |
| Open | 0.7500 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 12.50 |
| Expiry date | 2024-10-18 |
| Day's range | 0.7000 - 0.7500 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
Business WireAstria Therapeutics to Present at Upcoming Eastern Allergy Conference
BOSTON, May 24, 2024--Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced that it will present final STAR-0215 Phase 1a healthy subject data in an encore presentation at the upcoming Eastern Allergy Conference in Palm Beach, Florida on June 1, 2024.
Business WireAstria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Congress
BOSTON, May 23, 2024--Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced that it will present two posters at the upcoming European Academy of Allergy and Clinical Immunology (EAACI) Congress in Valencia, Spain on June 1, 2024.
Simply Wall St.We're Not Very Worried About Astria Therapeutics' (NASDAQ:ATXS) Cash Burn Rate
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
